Correlation Between Valneva SE and Inhibikase Therapeutics
Can any of the company-specific risk be diversified away by investing in both Valneva SE and Inhibikase Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Inhibikase Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and Inhibikase Therapeutics, you can compare the effects of market volatilities on Valneva SE and Inhibikase Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Inhibikase Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Inhibikase Therapeutics.
Diversification Opportunities for Valneva SE and Inhibikase Therapeutics
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Valneva and Inhibikase is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Inhibikase Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibikase Therapeutics and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Inhibikase Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibikase Therapeutics has no effect on the direction of Valneva SE i.e., Valneva SE and Inhibikase Therapeutics go up and down completely randomly.
Pair Corralation between Valneva SE and Inhibikase Therapeutics
Given the investment horizon of 90 days Valneva SE ADR is expected to under-perform the Inhibikase Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Valneva SE ADR is 2.26 times less risky than Inhibikase Therapeutics. The stock trades about -0.1 of its potential returns per unit of risk. The Inhibikase Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 282.00 in Inhibikase Therapeutics on September 12, 2024 and sell it today you would earn a total of 38.00 from holding Inhibikase Therapeutics or generate 13.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Valneva SE ADR vs. Inhibikase Therapeutics
Performance |
| Timeline |
| Valneva SE ADR |
| Inhibikase Therapeutics |
Valneva SE and Inhibikase Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Valneva SE and Inhibikase Therapeutics
The main advantage of trading using opposite Valneva SE and Inhibikase Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Inhibikase Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibikase Therapeutics will offset losses from the drop in Inhibikase Therapeutics' long position.| Valneva SE vs. NuCana PLC | Valneva SE vs. Sage Therapeutic | Valneva SE vs. Sellas Life Sciences | Valneva SE vs. Third Harmonic Bio |
| Inhibikase Therapeutics vs. Equillium | Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Valneva SE ADR | Inhibikase Therapeutics vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |